AACR-Hope Scarves Metastatic Breast Cancer Innovation and Discovery Grant
Funds innovative research on therapeutic targets and biomarkers in metastatic breast cancer, supporting basic, clinical, or translational science to advance treatment and understanding.
Funder: American Association for Cancer Research
Due Dates (Anticipated): July 2026
Funding Amounts: $50,000 for one year; no indirect costs allowed; funds may cover research expenses and limited travel.
Summary: Supports innovative basic, clinical, or translational research with direct relevance to metastatic breast cancer.
Key Information: Applicants must be independent investigators and AACR Active Members in good standing; postdocs and industry/government employees are not eligible.
Description
This grant aims to foster innovation and accelerate the translation of promising ideas in metastatic breast cancer research. It supports projects that may be basic, clinical, or translational in nature, with a focus on exploring potential therapeutic targets and biomarkers. The grant encourages bridging basic science with emerging treatment strategies and supports the next generation of cancer researchers. Applications are welcome from investigators currently studying metastatic breast cancer, as well as those with relevant experience in other areas of cancer or biomedical research, provided the proposed work is directly relevant to metastatic breast cancer.
